What’s Driving Pfizer’s Pursuit of AstraZeneca?

April 28 (Bloomberg) -- Bloomberg’s Drew Armstrong examines what Pfizer stands to gain from its $98.7 billion pursuit of AstraZeneca on Bloomberg Television’s “Market Makers.”
How Blueprint Is Accelerating Hong Kong's Tech Community
56:21 - March 3 -- Charlie Melvoin, project leader at Blueprint, and Henry Bott, business development leader, discuss the company's accelerator project for tech startups with Bloomberg's Rishaad Salamat on "Trending Business."
  • Sharp Sells Off After Report Company Seeks Capital
  • QIC's Peter: Why the RBA Will Be Cutting Rates Further
  • Jefferies's Darby on China, U.S. Markets, Economies